annual D&A:
$904.00K-$184.00K(-16.91%)Summary
- As of today (September 18, 2025), AMLX annual depreciation & amortization is $904.00 thousand, with the most recent change of -$184.00 thousand (-16.91%) on December 31, 2024.
- During the last 3 years, AMLX annual D&A has risen by +$852.00 thousand (+1638.46%).
- AMLX annual D&A is now -16.91% below its all-time high of $1.09 million, reached on December 31, 2023.
Performance
AMLX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$141.00K-$15.00K(-9.62%)Summary
- As of today (September 18, 2025), AMLX quarterly depreciation & amortization is $141.00 thousand, with the most recent change of -$15.00 thousand (-9.62%) on June 1, 2025.
- Over the past year, AMLX quarterly D&A has dropped by -$67.00 thousand (-32.21%).
- AMLX quarterly D&A is now -55.24% below its all-time high of $315.00 thousand, reached on March 31, 2024.
Performance
AMLX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$678.00K-$67.00K(-8.99%)Summary
- As of today (September 18, 2025), AMLX TTM depreciation & amortization is $678.00 thousand, with the most recent change of -$67.00 thousand (-8.99%) on June 1, 2025.
- Over the past year, AMLX TTM D&A has dropped by -$448.00 thousand (-39.79%).
- AMLX TTM D&A is now -43.45% below its all-time high of $1.20 million, reached on March 31, 2024.
Performance
AMLX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AMLX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.9% | -32.2% | -39.8% |
| 3 y3 years | +1638.5% | +34.3% | +384.3% |
| 5 y5 years | +100.0% | - | - |
AMLX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.9% | +1638.5% | -55.2% | +34.3% | -43.5% | +384.3% |
| 5 y | 5-year | -16.9% | >+9999.0% | -55.2% | +1310.0% | -43.5% | +6680.0% |
| alltime | all time | -16.9% | >+9999.0% | -55.2% | +1310.0% | -43.5% | +6680.0% |
AMLX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $141.00K(-9.6%) | $678.00K(-9.0%) |
| Mar 2025 | - | $156.00K(-2.5%) | $745.00K(-17.6%) |
| Dec 2024 | $904.00K(-16.9%) | $160.00K(-27.6%) | $904.00K(-13.5%) |
| Sep 2024 | - | $221.00K(+6.3%) | $1.04M(-7.2%) |
| Jun 2024 | - | $208.00K(-34.0%) | $1.13M(-6.1%) |
| Mar 2024 | - | $315.00K(+4.7%) | $1.20M(+10.2%) |
| Dec 2023 | $1.09M | $301.00K(-0.3%) | $1.09M(+12.3%) |
| Sep 2023 | - | $302.00K(+7.5%) | $969.00K(+16.5%) |
| Jun 2023 | - | $281.00K(+37.7%) | $832.00K(+26.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $204.00K(+12.1%) | $656.00K(+34.7%) |
| Dec 2022 | $487.00K(+836.5%) | $182.00K(+10.3%) | $487.00K(+59.7%) |
| Sep 2022 | - | $165.00K(+57.1%) | $305.00K(+117.9%) |
| Jun 2022 | - | $105.00K(+200.0%) | $140.00K(+211.1%) |
| Mar 2022 | - | $35.00K(+250.0%) | $45.00K(+125.0%) |
| Dec 2021 | $52.00K(+5100.0%) | - | - |
| Jun 2021 | - | $10.00K(0.0%) | $20.00K(+100.0%) |
| Mar 2021 | - | $10.00K | $10.00K |
| Dec 2020 | $1000.00(>+9900.0%) | - | - |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Amylyx Pharmaceuticals, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. annual D&A year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. quarterly D&A year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. TTM D&A year-on-year change?
What is Amylyx Pharmaceuticals, Inc. annual depreciation & amortization?
The current annual D&A of AMLX is $904.00K
What is the all time high annual D&A for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high annual depreciation & amortization is $1.09M
What is Amylyx Pharmaceuticals, Inc. annual D&A year-on-year change?
Over the past year, AMLX annual depreciation & amortization has changed by -$184.00K (-16.91%)
What is Amylyx Pharmaceuticals, Inc. quarterly depreciation & amortization?
The current quarterly D&A of AMLX is $141.00K
What is the all time high quarterly D&A for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high quarterly depreciation & amortization is $315.00K
What is Amylyx Pharmaceuticals, Inc. quarterly D&A year-on-year change?
Over the past year, AMLX quarterly depreciation & amortization has changed by -$67.00K (-32.21%)
What is Amylyx Pharmaceuticals, Inc. TTM depreciation & amortization?
The current TTM D&A of AMLX is $678.00K
What is the all time high TTM D&A for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high TTM depreciation & amortization is $1.20M
What is Amylyx Pharmaceuticals, Inc. TTM D&A year-on-year change?
Over the past year, AMLX TTM depreciation & amortization has changed by -$448.00K (-39.79%)